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Fast diagnostic test for the identification of an
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(exemplified on a DNA test for recurrent
mutations of the gene MMR)
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Hereditary nonpolyposis colorectal cancer (Lynch Syn-
drome, LS) is a genetic disorder, where family members
are at high risk of developing cancer of the colon, endo-
metrium, small intestine and urinary tract. The cause
for LS is due to constitutional mutations in several mis-
match repair genes (MMR) mainly in MLH1, MSH2 and
MSH6.
The Polish population has been well characterized by
a large study comprising ~1000 LS-suspected families.
Most nucleotide substitutions (about 90%) were discov-
ered mainly by DHPLC (denaturing high-performance
liquid chromatography) or sequencing, whereas deletion
of one or more exons (about 10% of all mutations) were
detected mainly by MLPA (multiplex ligation-dependent
probe amplification) [1,2].
Over 60% families of the former study, which were
affected by recurrent MMR mutations, were taken as a
basis to design the following iPLEX/TaqMan test, that
allows simultaneous testing of almost all recurrent
mutations in only analysis [3] .
The drawback of this kind of analysis are the high
costs of the machines (Sequenom), for which a reason-
able cost-effectiveness is achieved only for large series of
probes. Thus the approach is convenient only for high-
throughput laboratories.
However the present approach is cost-effective even
for testing individual patients. The present test, based
on a Taqman PCR analysis, allows a fast identification
of the 20 most frequent mutations of the genes MLH1
and MSH2. An analogous test for recurrent mutations
of the gene APC could, in a similar way, accelerate the
molecular diagnostic of predisposition to FAP.
Published: 12 January 2012
References
1. Kurzawski G, et al: Germline MSH2 and MSH1 mutational spectrum
including large rearrangements in HNPCC families from Poland (update
study). Clinical Genetics 2006, 69:40-47.
2. Suchy J, et al: Frequency and nature of hMSH6 germline mutations in
Polish patients with colorectal, endometrial and ovarian cancers. Clin.
Genet 2006, 70:68-70.
3. Dymerska D, et al: Combined iPLEX and TaqMan assays to screen for 45
common mutations in Lynch syndrome and FAP patients. J Mol Diag
2010, 12:82-90.
doi:10.1186/1897-4287-10-S1-A13
Cite this article as: Kurzawski et al.: Fast diagnostic test for the
identification of an increased genetic predisposition to colon cancer
(exemplified on a DNA test for recurrent mutations of the gene MMR).
Hereditary Cancer in Clinical Practice 2012 10(Suppl 1):A13.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: gkurz@sci.pam.szczecin.pl
International Hereditary Cancer Center, Pomeranian Medical University,
Szczecin, Poland
Kurzawski et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 1):A13
http://www.hccpjournal.com/content/10/S1/A13
© 2012 Kurzawski et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.